CIK: 0001306923 · Show all filings
Period: Q4 2021 (← Previous) (Next →)
Filing Date: Feb 14, 2022
Total Value ($000): $1,564,771 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BMRN | BIOMARIN PHARMACEUTICAL INC | 2,212,950 | $195,514 | 12.5% | $83.16 | -0.8% | COM | 09061G101 |
| — | ABIOMED INC | 519,033 | $186,421 | 11.9% | $81.43 | — | COM | 003654100 |
| INSM | INSMED INC | 6,025,706 | $164,140 | 10.5% | $17.79 | +60.7% | COM | 457669307 |
| UTHR | UNITED THERAPEUTICS CORP | 687,206 | $148,491 | 9.5% | $89.23 | +120.0% | COM | 91307C102 |
| FOLD | AMICUS THERAPEUTICS INC | 10,114,043 | $116,817 | 7.5% | $9.52 | +17.1% | COM | 03152W109 |
| STAA | STAAR SURGICAL CO | 1,140,511 | $104,129 | 6.7% | $14.28 | +651.5% | COM | 852312305 |
| BIIB | BIOGEN INC | 385,000 | $92,369 | 5.9% | $264.06 | -2.6% | COM | 09062X103 |
| PRTA | PROTHENA CORP PLC | 1,685,282 | $83,253 | 5.3% | $21.46 | +158.4% | COM | G72800108 |
| — | REVANCE THERAPEUTICS INC | 4,369,366 | $71,308 | 4.6% | $22.01 | — | COM | 761330109 |
| ACAD | ACADIA PHARMACEUTICALS INC | 2,337,877 | $54,566 | 3.5% | $33.89 | -40.7% | COM | 004225108 |
| VNDA | VANDA PHARMACEUTICALS INC | 2,834,244 | $44,469 | 2.8% | $11.21 | +55.4% | COM | 921659108 |
| EHTH | EHEALTH INC | 1,615,570 | $41,197 | 2.6% | $60.36 | -45.0% | COM | 28238P109 |
| ALGN | ALIGN TECHNOLOGY INC | 55,405 | $36,411 | 2.3% | $114.31 | +462.4% | COM | 016255101 |
| — | KARYOPHARM THERAPEUTICS INC | 5,470,452 | $35,175 | 2.2% | $16.61 | — | COM | 48576U106 |
| — | SAGE THERAPEUTICS INC | 781,730 | $33,255 | 2.1% | $47.83 | — | COM | 78667J108 |
| — | GRITSTONE ONCOLOGY INC | 2,356,282 | $30,302 | 1.9% | $9.42 | — | COM | 39868T105 |
| GOSS | GOSSAMER BIO INC | 1,772,950 | $20,052 | 1.3% | $11.85 | +0.3% | COM | 38341P102 |
| ALKS | ALKERMES PLC | 754,200 | $17,543 | 1.1% | $22.36 | +17.6% | COM | G01767105 |
| ANAB | ANAPTYSBIO INC | 436,592 | $15,172 | 1.0% | $19.06 | +66.4% | COM | 032724106 |
| — | EPIZYME INC | 5,485,213 | $13,713 | 0.9% | $14.39 | — | COM | 29428V104 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 598,900 | $13,110 | 0.8% | $16.84 | +9.7% | COM | 87164F105 |
| — | KEZAR LIFE SCIENCES INC | 656,200 | $10,972 | 0.7% | $5.16 | — | COM | 49372L100 |
| — | CLOVIS ONCOLOGY INC | 3,997,826 | $10,834 | 0.7% | $47.56 | — | COM | 189464100 |
| CYTK | CYTOKINETICS INC | 123,686 | $5,638 | 0.4% | $6.71 | +474.8% | COM | 23282W605 |
| TVTX | TRAVERE THERAPEUTICS INC | 166,069 | $5,155 | 0.3% | $23.56 | +19.6% | COM | 89422G107 |
| — | ZOGENIX INC | 183,800 | $2,987 | 0.2% | $20.95 | — | COM | 98978L204 |
| — | MAGENTA THERAPEUTICS INC | 432,300 | $1,915 | 0.1% | $7.38 | — | COM | 55910K108 |
| NVAX | NOVAVAX INC | 12,500 | $1,788 | 0.1% | $171.82 | 0.0% | COM | 670002401 |
| — | RIGEL PHARMACEUTICALS INC | 652,395 | $1,729 | 0.1% | $3.40 | — | COM | 766559603 |
| AZN | ASTRAZENECA PLC-SPONS ADR | 29,260 | $1,704 | 0.1% | $60.06 | — | COM | 046353108 |
| MIRM | MIRUM PHARMACEUTICALS INC | 64,700 | $1,032 | 0.1% | $15.56 | 0.0% | COM | 604749101 |
| — | ALIMERA SCIENCES INC | 200,919 | $1,031 | 0.1% | $6.30 | — | COM | 016259202 |
| KLDO | KALEIDO BIOSCIENCES INC | 341,030 | $815 | 0.1% | $13.76 | -70.4% | COM | 483347100 |
| ALDX | ALDEYRA THERAPEUTICS INC | 160,800 | $643 | 0.0% | $7.10 | +7.5% | COM | 01438T106 |
| TCMD | TACTILE SYSTEMS TECHNOLOGY I | 27,100 | $516 | 0.0% | $39.74 | -28.6% | COM | 87357P100 |
| — | MARINUS PHARMACEUTICALS INC | 31,330 | $372 | 0.0% | $15.48 | — | COM | 56854Q200 |
| URGN | UROGEN PHARMA LTD | 24,500 | $233 | 0.0% | $27.01 | -47.8% | COM | M96088105 |